1Fraser-Andrews EA, Russell-Jones R, Woolford AJ, et al.Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sezary syndrome[J]. Cancer, 2001, 92(7): 1745-1752.
2Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the international society for cutaneous lymphomas[J]. JAAD, 2002, 46(1): 95-106.
3Kashani-Sabet M, McMillan A, Zackheim HS. A modified staging classification for cutaneous T-cell lymphoma[J]. JAAD,2001,45(5): 700-706.
4Fitzpatricks. Dermatology in General Medicine[M]. 5th ed. New York: McGran-Hill, 1999. 1234.
6Mehmet H,Sedat A,Adem A,et al.Mycosis fungoides with involvement of the oral cavity[J].Journal of the European Academy of Dermatology and Venerology,1998,10:253-256.
7Vonderheid EC,Bernengo MG,Bung G,et al.Update on erythrodermic cutaneous T-cell lymphoma:report of the International Society for Cutaneous Lymphomas[J].J Am Acad Dermatol,2002,46(1):95-106.
8Flink-Puches R.Primary cutaneous lymphomas:applicability of current classification schemes(European Organization for Resarch and Treatment of Cancer,World Health Organization)based on clinicopathologic features observed in a large group of patients[J].Blood,2002,99:800-805.
9Abel EA.Skin neoplasias including cutaneous lymphoma,melanoma,and others:unapproved treatments or indications[J].Clin Dermatol,2000,18(2):201-210.
10Dutz JP,Ho VC.Immunosuppressive agents in dermatology.An update[J].Dermatol Clin,1998,16(2):235-251.
